1. Home
  2. NTB vs TARS Comparison

NTB vs TARS Comparison

Compare NTB & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank of N.T. Butterfield & Son Limited (The) Voting

NTB

Bank of N.T. Butterfield & Son Limited (The) Voting

HOLD

Current Price

$60.83

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$70.07

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTB
TARS
Founded
1858
2016
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Commercial Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.7B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
NTB
TARS
Price
$60.83
$70.07
Analyst Decision
Hold
Buy
Analyst Count
4
6
Target Price
$53.75
$89.00
AVG Volume (30 Days)
214.6K
890.8K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
3.66%
N/A
EPS Growth
N/A
48.21
EPS
N/A
N/A
Revenue
N/A
$451,360,000.00
Revenue This Year
$0.84
$56.43
Revenue Next Year
$4.16
$30.19
P/E Ratio
$9.64
N/A
Revenue Growth
N/A
146.71
52 Week Low
$40.59
$38.51
52 Week High
$61.11
$85.25

Technical Indicators

Market Signals
Indicator
NTB
TARS
Relative Strength Index (RSI) 64.22 64.49
Support Level $57.71 $59.60
Resistance Level N/A $77.35
Average True Range (ATR) 1.02 3.77
MACD 0.08 0.62
Stochastic Oscillator 91.78 83.68

Price Performance

Historical Comparison
NTB
TARS

About NTB Bank of N.T. Butterfield & Son Limited (The) Voting

Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It offers banking services, comprising retail and corporate banking, and wealth management services, which consist of trust, private banking, and asset management business. The company operates through four reportable segments: Bermuda, Cayman, Channel Islands and the UK, and Other. In its Bermuda and Cayman segments, the company offers retail banking and wealth management services. In the Channel Islands and the UK segment, the company offers retail and corporate banking and wealth management services, and the Other segment includes its operations in the Bahamas, Canada, Mauritius, Singapore, and Switzerland. Maximum revenue for the company is generated from its business in Bermuda.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: